Methods for Monoclonal Antibody Generation
US-2024228595-A1 · Jul 11, 2024 · US
US9255294B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9255294-B2 |
| Application number | US-201013500439-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 5, 2010 |
| Priority date | Oct 5, 2009 |
| Publication date | Feb 9, 2016 |
| Grant date | Feb 9, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A genetic polymorphism and a hair shape susceptibility gene that are related to hair shape, and a method for determining the genetic susceptibility to hair shape in individual test subjects are provided. Disclosed is a hair shape susceptibility gene, which overlaps with a haplotype block in 1q21.3 region (D1S2696 to D1S2346) of human chromosome 1 and comprises a portion or the entirety of the base sequence of the haplotype block, wherein the haplotype block is determined by a linkage disequilibrium analysis conducted on a single nucleotide polymorphism (SNP) marker whose allele frequency differs statistically significantly between a group having a curly hair trait and a group having a non-curly hair trait, and consists of a base sequence set forth in any one of SEQ ID NO: 1 to NO: 5.
Opening claim text (preview).
The invention claimed is: 1. A method for evaluating or selecting a hair shape regulating agent, comprising the following steps (a) to (e): (a) culturing cells in the presence of a test substance, wherein the cells are capable of expressing a human IVL gene or a protein encoded by the IVL gene, and wherein the cells are selected from the group consisting of human hair follicle tissue cells and hair root area-derived cells; (b) measuring the amount of expression of the IVL gene or the IVL protein in the cells that were cultured in the presence of the test substance in step (a); (c), selecting, based on the results of step (b), a test substance that increases or decreases the amount of expression of the IVL gene or the IVL protein as compared to that in control cells cultured in the absence of the test substance; (d) culturing a human hair follicle in organ culture in the presence of the test substance that is selected in step (c); (e) measuring the degree of curl of the hair follicle's hair shaft; and (f) selecting a test substance from step (e) that alters the degree of curl of the hair follicle's hair shaft, as compared to that of a control hair follicle cultured in the absence of the test substance, as a hair shape regulating agent, wherein a test substance that increases the amount of expression of the IVL gene or the IVL protein, and also increases the degree of curl, is selected as a hair curling agent, and a test substance that decreases the amount of expression of the IVL gene or the IVL protein, and also decreases the degree of curl, is selected as a hair straightening agent. 2. The method of claim 1 , wherein the test substance increases the amount of expression of the IVL gene or the IVL protein. 3. The method of claim 1 , wherein the test substance decreases the amount of expression of the IVL gene or the IVL protein. 4. The method of claim 1 , wherein the IVL gene encodes a IVL protein having the amino acid sequence of SEQ ID NO: 51. 5. The method of claim 1 , wherein the sequence of the IVL gene is that of SEQ ID NO: 50. 6. The method of claim 1 , wherein the cells in step (a) are human hair follicle tissue cells. 7. The method of claim 1 , wherein the cells in step (a) are hair root area-derived cells. 8. A method for evaluating or selecting a hair shape regulating agent, comprising the following steps (a) to (g): (a) introducing a fusion gene to cells, wherein, in the fusion gene, a regulatory region of the human IVL gene is linked to and controls expression of a reporter gene, wherein the cells are capable of expressing an expression product of the reporter gene and are selected from the group consisting of human hair follicle tissue cells and hair root area-derived cells; (b) culturing the cells that contain the fusion gene of step (a) in the presence of a test substance, (c) measuring the amount of expression of the expression product of the reporter gene in the cells cultured in the presence of the test substance; (d) selecting, based on the comparison results of step (c), a test substance that increases or decreases the amount of the expression product of the reporter gene as compared to that in control cells cultured in the absence of the test substance; (e) culturing a human hair follicle in organ culture in the presence of the test substance that is selected in step (d); (f) measuring the degree of curl of the hair follicle's hair shaft; and (g) selecting a test substance from step (f) that alters the degree of curl of the hair follicle's hair shaft, as compared to that of a control hair follicle cultured in the absence of the test substance, as a hair shape regulating agent, wherein a test substance that increases the amount of expression of the reporter gene or the reporter protein, and also increases the degree of curl, is selected as a hair curling agent; and a test substance that decreases the amount of expression of the reporter gene or the reporter protein, and also decreases the degree of curl, is selected as a hair straightening agent. 9. The method of claim 8 , wherein the test substance increases the amount of expression of the reporter gene. 10. The method of claim 8 , wherein the test substance decreases the amount of expression of the reporter gene. 11. The method of claim 8 , wherein the sequence of the regulatory region of the IVL gene is that of SEQ ID NO. 57 . 12. The method of claim 8 , wherein the cells in step (a) are human hair follicle tissue cells. 13. The method of claim 8 , wherein the cells in step (a) are hair root area-derived cells.
Drugs for dermatological disorders · CPC title
Screening for cosmetic compounds · CPC title
Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes · CPC title
Active agents used in cell culture processes, e.g. differentation · CPC title
involving nucleic acids · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.